711 filings
Page 26 of 36
8-K
mxhh73jobv4 syut
23 Feb 18
KemPharm Announces FDA Approval of Apadaz™ (benzhydrocodone and acetaminophen) for the Short-Term Management of Acute Pain
12:00am
SC 13G/A
q4zff
14 Feb 18
Kempharm, Inc
12:00am
SC 13G/A
8y31wauwwhmspah
14 Feb 18
Kempharm, Inc
12:00am
SC 13G/A
ptlfyd rcxjmb
12 Feb 18
Kempharm, Inc
12:00am
8-K
g8kqtz
31 Jan 18
Departure of Directors or Certain Officers
12:00am
4
ko4j36qcstuj1wjp
29 Jan 18
KEMPHARM / Travis C Mickle ownership change
12:00am
4
7zmc7qd84ayfjhwjnemr
29 Jan 18
KEMPHARM / Sven Guenther ownership change
12:00am
4
162f6e gr
29 Jan 18
KEMPHARM / R. LaDuane Clifton ownership change
12:00am
4
m7e38in0 kt8wzy66fwe
29 Jan 18
KEMPHARM / Gordon K Johnson ownership change
12:00am
4
66d7quanrad 4x5wj4p
29 Jan 18
KEMPHARM / Timothy J. Sangiovanni ownership change
12:00am
4
11b0bzk8gs0hr
29 Jan 18
KEMPHARM / Daniel L Cohen ownership change
12:00am
SC 13G/A
63jpuwz1trws t2
29 Jan 18
Kempharm, Inc
12:00am
4
rkbqa0s
29 Nov 17
KEMPHARM / Daniel L Cohen ownership change
12:00am
8-K
zs3g 9822znq8rjp
9 Nov 17
KemPharm Reports Third Quarter 2017 Results and Provides Corporate Update
12:00am
8-K
ch3uo018 riqo92zra
2 Oct 17
Other Events
12:00am
8-K
9nba9 g5plm7gec54
26 Sep 17
Other Events
12:00am
4
mdpb pbdcmeveuquw
25 Sep 17
KEMPHARM / R. LaDuane Clifton ownership change
12:00am
8-K
n8fczpn1iuhc
19 Sep 17
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
SC 13G/A
yopk4q8b
15 Sep 17
Kempharm, Inc
12:00am